Status
Conditions
Treatments
About
This clinical study is designed to evaluate the diagnostic performance of VisioCyt test, which would improve the early diagnosis of bladder cancer in order to optimize the management of individual patients as part of a cancer diagnostic monitoring. The diagnostic method of VisioCyt® device is based on the analysis by transmission and fluorescence, of urinary cytology slides prepared according to the protocol VisioCyt.
Full description
This clinical trial is divided into two main phases:
I. The first one involves the construction of better image processing algorithm from a learning sample. The learning sample will include 600 virtual slides made from the urine sample of the first 600 patients enrolled.
II. The second one, will evaluate from an evaluation sample, the diagnostic performance of the test VisioCyt, to identify patients with versus without bladder tumors, using as comparator the results of the examination of reference: histology. The evaluation sample will include 400 slides, made from the urine sample of the last 400 patients enrolled.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Age ≥18 years
Patient affiliated to a social security system
Patient able to understand the protocol.
Signature of patient consent form before the start of the study
Negative urine culture
Patient for which is programmed a bladder Endoscopy for :
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
1,360 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal